By Topic

When to initiate HIV therapy: a control theoretic approach

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

3 Author(s)
Jeffrey, A.M. ; Dept. of Electr., Electron., & Comput. Eng., Pretoria Univ., South Africa ; Xiaohua Xia ; Craig, I.K.

This paper shows an application of control theory to human immunodeficiency virus (HIV)/AIDS models. Minimum singular value decomposition is applied to HIV/AIDS models to measure the extent to which the different stages in the progression of HIV/AIDS disease are controllable and, consequently, when best to initiate therapy such that the general objectives of therapy are satisfied. Simulations are used to demonstrate the effect of treatment at various stages. Comparisons are made between mono-class and combination therapies and between when therapy is initiated at the acute infection, asymptomatic and the advanced stages.

Published in:

Biomedical Engineering, IEEE Transactions on  (Volume:50 ,  Issue: 11 )